MAT
37
3
RL
79
4
AON
32
13
QCOM
84
2
SRCL
57
18
R
59
2
DO
71
2
DE
32
9
HSY
54
-3
BBY
38
-5
ADBE
41
-8
AEE
40
2
CNP
59
2
CTAS
53
-8
MAR
42
7
MAC
67
2
IVZ
55
2
HRL
30
3
SLG
55
2
FMC
27
3
MAT
37
3
RL
79
4
AON
32
13
QCOM
84
2
SRCL
57
18
R
59
2
DO
71
2
DE
32
9
HSY
54
-3
BBY
38
-5
ADBE
41
-8
AEE
40
2
CNP
59
2
CTAS
53
-8
MAR
42
7
MAC
67
2
IVZ
55
2
HRL
30
3
SLG
55
2
FMC
27
3
Financhill
Back

Minerva Neurosciences Vs. Karyopharm Therapeutics Industry Stock Comparison

Sell
27

NERV
Minerva Neurosciences

Last Price:
2.40
Seasonality Move:
18.51%
Buy
53

KPTI
Karyopharm Therapeutics

Last Price:
0.99
Seasonality Move:
-8.34%
Sell
27
Minerva Neurosciences (NERV) is a Sell

Is Minerva Neurosciences a Buy, Sell or Hold?

  • The current Minerva Neurosciences [NERV] share price is $2.44. The Score for NERV is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NERV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Karyopharm Therapeutics (KPTI) is a Buy

Is Karyopharm Therapeutics a Buy, Sell or Hold?

  • The current Karyopharm Therapeutics [KPTI] share price is $1.05. The Score for KPTI is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • KPTI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NERV Stock Price Chart

What is Minerva Neurosciences's stock price today?

  • The Minerva Neurosciences share price today is $2.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NERV is experiencing slight selling pressure.

KPTI Stock Price Chart

What is Karyopharm Therapeutics's stock price today?

  • The Karyopharm Therapeutics share price today is $1.05
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.

NERV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.05 Sell
Relative Strength Index (14 RSI): 42.97 Sell
Chaikin Money Flow: -5672 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.39 - 2.53) Sell
Bollinger Bands (100): (1.77 - 7.57) Sell

KPTI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 41.29 Sell
Chaikin Money Flow: -626441 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.07 - 1.13) Sell
Bollinger Bands (100): (0.94 - 1.4) Sell

NERV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.51 Sell
20-day SMA: 2.46 Sell
50-day SMA: 2.51 Sell
200-day SMA: 5.65 Sell
8-day EMA: 2.49 Sell
20-day EMA: 2.49 Sell
50-day EMA: 2.94 Sell
200-day EMA: 4.85 Sell

KPTI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.12 Sell
20-day SMA: 1.1 Sell
50-day SMA: 1.22 Sell
200-day SMA: 1.12 Sell
8-day EMA: 1.1 Sell
20-day EMA: 1.12 Sell
50-day EMA: 1.16 Sell
200-day EMA: 1.41 Sell

Minerva Neurosciences Earnings Growth & NERV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.17 per share, an increase this year of $2.49 per share, and a decrease next year of $1.83 per share.

Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.34 per share.

Minerva Neurosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Karyopharm Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):